Proton and Carbon Ion Radiotherapy for Cervical Cancer
The aim of this study is to evaluate the toxicity and tolerance of proton and carbon ion radiotherapy (PCRT) for cervical cancer.
Cervical Cancer
RADIATION: proton and carbon ion radiotherapy
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0, Number of participants with treatment-related adverse events as assessed by CTCAE v4.0, through study completion, an average of 1 year
overall survival rate, overall survival rate, 3 years|local control rate, local control rate, 3 years|progression-free survival, progression-free survival, 3 years|distant metastasis-free survival, distant metastasis-free survival, 3 years
To retrospectively analyze cervical cancer patients received radical proton and carbon radiotherapy in our center. The acute and late toxicities, overall survival (OS), local control rate (LC), progression-free survival (PFS) and distant metastasis-free survival (DMFS) were analyzed.